{"id":"NCT02554786","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma","officialTitle":"A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-29","primaryCompletion":"2018-11-21","completion":"2019-06-28","firstPosted":"2015-09-18","resultsPosted":"2020-03-05","lastUpdate":"2020-03-05"},"enrollment":2216,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Indacaterol acetate/Mometasone furoate","otherNames":["QMF149"]},{"type":"DRUG","name":"Mometasone furoate","otherNames":[]},{"type":"DRUG","name":"Salmeterol xinafoate/fluticasone propionate","otherNames":[]}],"arms":[{"label":"QMF149 150/160 µg","type":"EXPERIMENTAL"},{"label":"QMF149 150/320 µg","type":"EXPERIMENTAL"},{"label":"MF 400 µg","type":"ACTIVE_COMPARATOR"},{"label":"Salmeterol /fluticasone 50/500 μg","type":"ACTIVE_COMPARATOR"},{"label":"MF 800 μg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the trial is to evaluate the efficacy and safety of two different doses of QMF149 (QMF149 150/160 µg and QMF149 150/320 µg via Concept1) over two respective MF doses (MF 400 µg and MF 800 µg via Twisthaler® (total daily dose)) in poorly controlled asthmatic participants as determined by pulmonary function testing, and effects on asthma control","primaryOutcome":{"measure":"Trough Forced Expiratory Volume in One Second (Trough FEV1) at Week 26","timeFrame":"26 weeks","effectByArm":[{"arm":"QMF149 150/320 μg","deltaMin":2.383,"sd":0.0159},{"arm":"QMF149 150/160 μg","deltaMin":2.387,"sd":0.016},{"arm":"MF 800 μg","deltaMin":2.25,"sd":0.0162},{"arm":"MF 400 μg","deltaMin":2.176,"sd":0.0162},{"arm":"Salmeterol/Fluticasone 50/500 μg","deltaMin":2.346,"sd":0.016}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":13},"locations":{"siteCount":388,"countries":["United States","Bulgaria","China","Croatia","Czechia","Egypt","Estonia","Germany","Guatemala","Hungary","India","Ireland","Japan","Latvia","Lithuania","Mexico","Poland","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","United Kingdom"]},"refs":{"pmids":["36472162","34452934","32653075"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":443},"commonTop":["Asthma","Nasopharyngitis","Upper respiratory tract infection","Headache","Bronchitis"]}}